Immediate IUD insertion
ProcedureInsertion of either Paraguard or Mirena IUD within minutes of completing suction aspiration procedure between 5 and 12 weeks gestation
NCT Number: NCT00562276
The purpose of this multi-center clinical trial is to evaluate the safety and effectiveness of inserting an intrauterine device (IUD) immediately after a suction aspiration procedure compared to inserting the IUD 2-6 weeks after the procedure. This study will also evaluate how satisfied women are with the timing of their IUD placement. Subjects will be able to choose between the Paraguard IUD or the Mirena IUD.
The researchers hypothesize that:
1. the expulsion rates measured at 1, 3 and 6 months will be clinically equivalent with immediate insertion compared with delayed insertion, 2. satisfaction and tolerance of side effects will be higher with immediate IUD insertion compared with delayed insertion, and 3. overall IUD use/continuation rates measured at 1, 3 and 6 months will be higher with immediate IUD insertion compared with delayed insertion.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 4
Emory University, Atlanta, Georgia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Insertion of either Paraguard or Mirena IUD within minutes of completing suction aspiration procedure between 5 and 12 weeks gestation
Time frame: 1, 3 and 6 months after insertion
Time frame: 1, 3 and 6 months after insertion
Looking for future studies?
Notify MeOregon Health and Science University
Other
Immediate Versus Delayed IUD Insertion Following Suction Aspiration Between 5 and 12 Weeks Gestation: a Randomized Trial
Acronym: PAIR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05139121
Contraception
Mobile, Alabama, United States
View Trial DetailsNCT03067272
Contraception
New York, United States
View Trial DetailsNCT06664034
Cancer, Contraception
Brawley, California, United States
View Trial DetailsNCT05818254
Autoimmune Diseases, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial Details